Sign in

CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company

PALISADE BIO, INC.

Sign in to watch
Ticker
PALI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522007292
Phone
(858) 704-4900
Business address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
Former names
PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
  1. 4 Option exercise Director acquired 12,800 shares (option exercise)
  2. 4 Shares withheld for taxes Chief Medical Officer gave up 2,153 shares (to pay taxes)
  3. 4 Option exercise CEO, CFO, Director acquired 6,642 shares (option exercise)
  4. 4 Open-market buy CEO, CFO, Director bought 10,000 shares at $0.47 ($4,692)
  5. 4 Open-market buy CEO, CFO, Director bought 10,000 shares at $0.56 ($5,590)
  6. 4 Open-market buy Director bought 10,000 shares at $0.61 ($6,050)
  7. 4 Option exercise CEO, CFO, Director acquired 1,309 shares (option exercise)
  8. 4 Option exercise CEO, CFO, Director acquired 5,559 shares (option exercise)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award CEO, CFO, Director acquired 10,000 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Shares withheld for taxes Chief Medical Officer gave up 1,630 shares (to pay taxes)
  19. 4 Option exercise CEO, CFO, Director acquired 3,475 shares (option exercise)
  20. 4 Shares withheld for taxes CEO, CFO, Director gave up 397 shares (to pay taxes)

Page 4 of 18 · 343 filings